« Return to News | CROs/Service Providers

ClinTech Relocates To Scotland

Tuesday, December 11, 2007 06:21 AM

ClinTec International, a CRO based in the UK, is moving it global headquarters to Scotland from its current offices in Windsor. The office will be in Glasgow, Scotland.

The headquarters will house all of the company’s corporate functions including sales, human resources, IT, finance and marketing as well as clinical operations. The move is being assisted by a $2.7 million Regional Selective Assistance Grant from the Scottish Enterprise—an economic development agency funded by the Scottish government.

ClinTec has pledged to create 240 new jobs over the next three years. The company stated one of the incentives to relocate to the region is its highly skilled talent pool available due to the many universities and academic research institutes. More than a dozen CROs maintain operations in Scotland, including Quintiles, Aptuit, Charles River Laboratories and BioReliance.

In August, PPD obtained a $9.1 million RSA grant to the construction of a 34,000-square-foot office in Lanarkshire, Scotland to support its late-stage services.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.